Document:

Execution
Version

 

ProPhase
Labs, Inc. 

12%
Secured Promissory Note – Series A

and
Warrant

 

SUBSCRIPTION
AGREEMENT

 

1.
SUBSCRIPTION

 

The
undersigned subscriber hereby subscribes for a One Million Dollar ($1,000,000) 12% Secured Promissory Note – Series A due
June 15, 2017 (the “Note”), together with the Warrant acquired simultaneously therewith (the “Warrant”),
from ProPhase Labs, Inc. (the “Company”), a Delaware corporation having its principal place of
business at 621 N. Shady Retreat Road, Doylestown PA 18901. The undersigned understands the Note is one of a series of 12% Secured
Promissory Notes- Series A in the aggregate amount of up to $3,000,000 and that this subscription may be accepted or rejected
in whole or in part by the Company in its sole discretion. The Warrant is exercisable for shares of the Company’s common
stock, par value $0.0005 per share (the “Common Stock”). The number of shares issuable upon exercise
of the Warrant are collectively referred to herein as “Warrant Shares”. The Note, the Warrant and the
Warrant Shares are sometimes collectively referred to herein as the “Securities”. This subscription
is and shall be irrevocable (after passage of any right of rescission required by applicable state law) unless the Company for
any reason rejects this subscription. Unless otherwise defined herein, all capitalized terms used herein have the respective meanings
given to such terms in the Note, the Warrant or the Security Agreement granted in favor of all Series A Note holders simultaneously
with the issuance of the Note.

 

2.
REPRESENTATIONS AND WARRANTIES OF THE SUBSCRIBER

 

The
undersigned subscriber hereby represents and warrants to the Company that the following statements are true and correct as of
the date hereof:

 

(a)
The undersigned is an accredited investor within the meaning of Rule 501 of Regulation D promulgated under the Securities Act
of 1933, as amended (the “Securities Act”). The undersigned is an accredited investor because he, she
or it is (please check each applicable category):

 

	 	[  ]	 	i)	a
    bank is defined in Section 3(a)(2) of the 1933 Act;
	 	 	 	 	 
	 	[  ] 	 	ii)	a
    savings and loan association or other institution as defined in Section 3(a)(5)(A) of the 1933 Act, whether acting in its
    individual or fiduciary capacity;
	 	 	 	 	 
	 	[  ]	 	iii)	a
    broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended;
	 	 	 	 	 
	 	[  ]	 	iv)	an
    insurance company as defined in Section 2(13) of the 1933 Act;
	 	 	 	 	 
	 	[  ] 	 	v)	an
    investment company registered under the Investment Company Act of 1940, as amended (the “1940 Act”);

 

    	 

    	 	 	 

    

 

	 	[  ] 	 	vi)	a
    business development company, as defined in Section 2(a)(48) of the 1940 Act;
	 	 	 	 	 
	 	[  ]	 	vii)	a
    Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
    Business Investment Act of 1958;
	 	 	 	 	 
	 	[  ]	 	viii)	any
    plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its
    political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[  ]	 	ix)	any
    employee benefits plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision
    is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association,
    insurance company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000
    or, if a self-directed plan, with the investment decisions made solely by persons that are accredited investors;
	 	 	 	 	 
	 	[  ] 	 	x)	a
    private business development company, as defined in section 202(a)(22) of the Advisers Act;
	 	 	 	 	 
	 	[  ] 	 	xi)	an
    organization described in Section 501(c)(3) of the Internal Revenue Code of 1986 (the “Code”), not
    formed for the specific purpose of acquiring a Unit, and which has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[  ] 	 	xii)	a
    corporation, a Massachusetts or similar business trust, or a partnership, which entity was not formed for the specific purpose
    of acquiring a Unit, and which has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[X]	 	xiii)	a
    natural person whose individual net worth, or net worth together with that person’s spouse, exceeds $1,000,000 (excluding
    from the calculation the value of the undersigned’s primary residence but including any indebtedness secured by that
    residence that is in excess of that residence’s value);
	 	 	 	 	 
	 	[X]	 	xiv)	a
    natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with
    that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same
    income level in the current year;
	 	 	 	 	 
	 	[  ]	 	xv)	a
    trust with assets in excess of $5,000,000, not formed for the specific purpose of acquiring a Unit, whose purchase of the
    Note and Warrant is directed by a sophisticated person as described in Rule 506(b)(2)(ii) under the 1933 Act;
	 	 	 	 	 
	 	[  ]	 	xvi)	any
    director, executive officer, or principal of the Company; and/or
	 	 	 	 	 
	 	[  ] 	 	xvii)
    	any
    entity each of the equity owners of which satisfies one or more of the above conditions (i.e., are “accredited investors”).

 

    	 

    	 	 	 

    

 

(b)
The undersigned has evaluated carefully the undersigned’s financial resources and investment position and the risks associated
with this investment, and is able to bear the substantial economic risks of the undersigned’s investment in the Securities
for an indefinite period of time, can afford to hold the Note until maturity, and can afford a complete loss of the undersigned’s
investment in the Securities.

 

(c)
The undersigned either has such knowledge and experience in financial, tax and business matters or has received professional guidance
with respect to this investment, and is either alone, or with those providing such guidance, capable of evaluating the merits
and risks of an investment in the Securities and to make an informed investment decision with respect thereto.

 

(d)
The undersigned has been given the opportunity (i) to obtain information and to examine all documents relating to the Note and
Warrant, the Company and its business, (ii) to ask questions of, and to receive answers from, the management of the Company concerning
the Company, the Company’s business, and the terms and conditions of this investment, and (iii) to obtain any additional
information, to the extent the Company possesses such information or could acquire such information without unreasonable effort
or expense, necessary to verify the accuracy of any information previously furnished. All such questions have been answered to
the undersigned’s full satisfaction, and the undersigned has not relied on oral representations or oral information furnished
to the undersigned in connection with the purchase of the Securities which were in any way inconsistent with the Company’s
filings with the Securities Exchange Commission (“SEC Filings”).

 

(e)
The undersigned has had an opportunity to read and understand the provisions of this Subscription Agreement, to consult with the
undersigned’s adviser(s) or counsel regarding the operation and consequences of those provisions and has considered the
effect of those provisions on the undersigned.

 

(f)
No representations have been made to the undersigned concerning projected results, expected yields or any other prospective information
concerning operation of the Company other than those contained in the SEC Filings and accompanying exhibits.

 

(g)
The undersigned is acquiring the Securities for the undersigned’s own account or for the undersigned’s own account
as fiduciary of either an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”) for investment and not with a view to or for resale, in connection with public offering or distribution
of the Securities and without any present intention to sell the Securities at any particular event or circumstance. The undersigned
has no agreement or other arrangement with any person to sell, transfer or pledge all or any part of the Securities subscribed
for that would guarantee the undersigned any profit or protect against any loss with respect to the Securities.

 

(h)
The undersigned has no present obligation, indebtedness, or commitment, nor is any circumstance in existence that will compel
the undersigned to secure funds by the sale of the Securities, nor is the undersigned a party to any plan or undertaking that
would require or contemplate that proceeds from the sale of all or a part of the Securities be utilized in connection therewith.
The undersigned does not intend or anticipate that the undersigned will rely on this investment as a source of income.

 

(i)
The undersigned represents that the undersigned’s investment in the Securities involves a high degree of risk. The undersigned
takes full cognizance of, and understands such risks and has obtained sufficient information to evaluate the Company and the merits
and risks of an investment in the Securities.

 

    	 

    	 	 	 

    

 

(j)
The undersigned, if a corporation, partnership, trust or other entity, represents and warrants that it, or each of its equity
owners, was not organized for the specific purpose of acquiring the Securities and has other investments or business activities
or will make other investments or engage in other business activities, unless the undersigned has indicated the contrary to the
Company and specified the number of beneficial owners thereof, and the Company has consented in writing thereto. The undersigned,
if an individual, represents and warrants that the undersigned is not acquiring the Securities as a nominee, trustee, agent, or
representative for any other person, unless the undersigned has indicated the contrary to the Company and specified the number
of beneficial owners thereof, and the Company has consented in writing thereto.

 

(k)
None of the Securities offered under by this Subscription Agreement have been registered under the Securities Act or the securities
laws of certain states and are being offered and sold in reliance on exemptions from the registration requirements of the Securities
Act and such laws. The Securities, and any beneficial interest therein, are subject to restrictions on transferability and resale
and may not be transferred or resold, in whole or in part, except as permitted under the Securities Act and such laws pursuant
to registration or exemption therefrom. The Securities have not been approved or disapproved by the Securities and Exchange Commission
(the “SEC”), any state securities commission, or other regulatory authority, or have any of the foregoing
authorities passed on or endorsed the merits of the offering of the Securities or the accuracy or adequacy of the SEC Filings
with respect to such offering. Any representation to the contrary is unlawful. The undersigned understands that the Company is
under no obligation to register the Securities under the Securities Act. Each Subscriber must bear the economic risk of an investment
in the Securities, and the Securities may not be resold unless subsequently registered under applicable securities laws or unless
an exemption from such registration is available.

 

(l)
The undersigned confirms that the Securities were not offered to the undersigned by any means of general solicitation or general
advertising.

 

(m)
The undersigned’s representations and warranties in this Section 2 are true and correct as of the date hereof and shall
survive such delivery.

 

(n)
The undersigned is authorized and has full right and power to subscribe for the Securities and to perform the undersigned’s
obligations pursuant to the provisions hereof, and the person signing this Subscription Agreement and any other instrument executed
and delivered herewith on behalf of the prospective investor has been duly authorized by such entity and has full power and authority
to do so.

 

(o)
If the undersigned is an employee benefit plan subject to ERISA, then the undersigned acknowledges that the undersigned has been
informed of and understands the investment objectives and policies of, and the investment strategies that may be pursued by, the
Company and represents that the undersigned’s investment in the Securities (i) is permissible under the documents and instruments
governing such plan, (ii) satisfies the diversification requirements of section 404(a)(1)(C) of ERISA, (iii) is prudent considering
all the facts and circumstances, including the fact that there is not expected to by any public market for the disposition of
the Securities and (iv) is not a “prohibited transaction” within the meaning of section 406 of ERISA.

 

(p)
The undersigned understands and acknowledges that any projections regarding the business or finances of the Company contained
in the SEC Filings or any written materials received from the Company by the undersigned are based on numerous assumptions relying
on certain factors over which the Company has no control, and accordingly these projections are not guaranteed or warranted and
no assurance can be given to the undersigned about the returns that may be realized by an investment in the Securities. The undersigned
acknowledges that any reliance on any projections contained in the SEC Filings or such written materials shall be solely at the
undersigned’s risk and the undersigned is expected to undertake its own due diligence, inspections, investigations and assessments
as to the feasibility of the business of the Company.

 

    	 

    	 	 	 

    

 

(q)
The undersigned understands that the representations contained in this Subscription Agreement are made for the purpose of qualifying
the undersigned, or the entity for which the undersigned is acting, as a suitable investor for the purpose of establishing exemptions
from the registration or qualification provisions of the Securities Act and the securities laws of certain states for the offering
and sale of the Securities.

 

(r)
The undersigned is either a citizen of the United States of America (including an entity organized under the laws of any of the
50 states of the United States) or taxed as a resident of the United States of America for purposes of federal income tax.

 

(s)
The undersigned represents and warrants that its investment was not directly or indirectly derived from illegal activities, including
any activities that would violate United States Federal or State laws or any laws and regulations of other countries.

 

(t)
The undersigned acknowledges that United States Federal law, regulations and Executive Orders administered by the U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) prohibit the Company from, among other
things, engaging in transactions with, and the provision of services to, persons on the list of Specially Designated Nationals
and Blocked Persons and foreign countries and territories subject to U.S. sanctions administered by OFAC (together, the “OFAC
Maintained Sanctions”).

 

(u)
The undersigned represents and warrants that neither the undersigned, nor any person controlling, controlled by, or under common
control with, the undersigned, nor, to the best of the undersigned’s knowledge, any person having a beneficial interest
in the undersigned, or for whom the undersigned is acting as agent or nominee in connection with this investment, (i) is a country,
territory, person or entity subject to an OFAC Maintained Sanction or (ii) is a foreign shell bank as that term is defined by
the U.S. Treasury Department.

 

(v)
The undersigned represents and warrants that, if it is an entity designated as a “financial institution” in the USA
PATRIOT Act of 2001 (generally including banks, trust companies, thrift institutions, agencies or branches of foreign banks, investment
bankers, broker-dealers, investment companies, insurance companies, investment advisers, futures commission merchants, commodity
trading advisors, and commodity pool operators), it has implemented and enforces an anti-money laundering program (“AMLP”)
that is compliant with the USA PATRIOT Act of 2001 and that its AMLP, at a minimum:

 

	 	● 	Maintains
    and enforces a customer identification program in accordance with applicable regulatory requirements under Section 326 of
    the USA PATRIOT Act of 2001;
	 	 	 
	 	●	For
    each investor, client, customer, and principal, verifies and documents its investor, client, customer or principal nor any
    person that controls, is controlled by or is under common control with any investor, client, customer or principal (1) is
    a country, territory, person or entity subject to an OFAC Maintained Sanction, or (2) is a foreign shell bank as that term
    is defined by the U.S. Treasury Department;

 

    	 

    	 	 	 

    

 

	 	●	Includes
    reasonable internal procedures and controls to detect and report suspicious activities;
	 	 	 
	 	●	Designates
    a compliance officer for anti-money laundering responsibilities;
	 	 	 
	 	● 	Provides
    on-going employee training with respect to anti-money laundering policies and procedures; and
	 	 	 
	 	● 	Includes
    an independent audit function to test its AMLP.

 

(w)
The undersigned acknowledges and agrees that the Company, in complying with anti-money laundering statutes, regulations and goals,
may file voluntarily and/or as required by law suspicious activity reports (“SARs”) or any other information
with governmental and law enforcement agencies that identify transactions and activities that the Company or its agents reasonably
determine to be suspicious, or is otherwise required by law.

 

(x)
The undersigned acknowledges that the Company is prohibited by law from disclosing to third parties, including the undersigned,
any filing or the substance of any SAR.

 

(y)
The undersigned confirms that all information and documentation provided to the Company, including, but not limited to, all information
regarding the undersigned’s identity, business, investment objectives, and source of the funds to be invested in the Company,
is true and correct.

 

(z)
The undersigned represents and warrants that he/she/it is [  ]/ is not [X] (please check one) a senior foreign
political figure, or an immediate family member or close associate of a senior foreign political figure within the meaning of
the USA PATRIOT Act of 2001 and that the undersigned is [  ]/ is not [X] (please check one) making an investment
in the Company on behalf of such a person.

 

(aa)
The undersigned acknowledges that the Company may not accept any investment from the undersigned if the undersigned cannot truthfully
make the representations set forth in any of the preceding subsections.

 

3.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The
Company hereby represents and warrants to the undersigned subscriber that the following statements are true and correct:

 

(a)
Organization and Qualification. The Company is a corporation duly organized, validly existing and in good standing under
the laws of its state of incorporation. The Company is duly qualified to do business, and is in good standing in the states required
due to (a) the ownership or lease of real or personal property for use in the operation of the Company’s business or (b)
the nature of the business conducted by the Company except where failure to do so would not have a material adverse effect on
the Company. The Company has all requisite power, right and authority to own, operate and lease its properties and assets, to
carry on its business as now conducted, to execute, deliver and perform its obligations under this Subscription Agreement, the
Note, the Warrant and the security agreement executed in connection with the Note (collectively, the “Transaction
Documents”), and to carry out the transactions contemplated hereby and thereby. All actions on the part of the Company
and its officers and directors necessary for the authorization, execution, delivery and performance of the Transaction Documents,
the consummation of the transactions contemplated hereby and thereby, and the performance of all of the Company’s obligations
under Transaction Documents have been taken or will be taken prior to the closing. Each of the Transaction Documents have been
duly executed and delivered by the Company, and each of the Transaction Documents constitutes a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as may be limited by bankruptcy, reorganization,
insolvency, moratorium and similar laws of general application relating to or affecting the enforcement of rights of creditors,
and except as enforceability of the obligations hereunder are subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or law).

 

    	 

    	 	 	 

    

 

(b)
Issuance of Securities. The Securities to be issued to the undersigned investor pursuant to this Subscription Agreement
and the Warrant, as applicable, when issued and delivered in accordance with the terms of this Subscription Agreement and the
Warrant, as applicable, will be duly and validly issued and will be fully paid and non-assessable.

 

(c)
Authorization; Enforcement. The execution, delivery and performance of the Transaction Documents by the Company, and the
consummation of the transactions contemplated hereby and thereby, will not (a) constitute a violation (with or without the giving
of notice or lapse of time, or both) of any provision of any law or any judgment, decree, order, regulation or rule of any court,
agency or other governmental authority applicable to the Company or any of its Subsidiaries (as defined below), including, without
limitation, the rules of the Principal Market (defined below), (b) require any consent, approval or authorization of, or declaration,
filing or registration with, any person, including, without limitation, any shareholder of the Company and/or the Principal Market,
(c) result in a default (with or without the giving of notice or lapse of time, or both) under, acceleration or termination of,
or the creation in any party of the right to accelerate, terminate, modify or cancel, any agreement, lease, note or other restriction,
encumbrance, obligation or liability to which the Company or any of its Subsidiaries is a party or by which it is bound or to
which any assets of the Company or any of its Subsidiaries are subject, (d) result in the creation of any lien or encumbrance
upon the assets of the Company or any of its Subsidiaries, or upon any shares of Common Stock, preferred stock or other securities
of the Company or any of its Subsidiaries except for liens in favor of the holders of the Notes created by the Security Agreement,
(e) conflict with or result in a breach of or constitute a default under any provision of the certificate of incorporation or
bylaws of the Company or any of its Subsidiaries, or (f) invalidate or adversely affect any permit, license, authorization or
status used in the conduct of the business of the Company and its Subsidiaries.

 

(d)
SEC Filings. The Company is subject to, and in full compliance with, the reporting requirements of Section 13 or 15(d)
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has made available
to each subscriber through the EDGAR system true and complete copies of the Company’s filings for the prior two full fiscal
years plus any interim period (collectively, the “SEC Filings”). Since December 31, 2013, the SEC Filings,
when they were filed with the SEC (or, if any amendment with respect to any such document was filed, when such amendment was filed),
complied in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder
and did not, as of such date, contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. All reports and statements required to be filed by the Company under the Exchange Act have been filed, together with
all exhibits required to be filed therewith. The Company and each of its direct and indirect subsidiaries, if any (collectively,
the “Subsidiaries”), are engaged in all material respects only in the business described in the SEC
Filings, and the SEC Filings contain a complete and accurate description in all material respects of the business of the Company
and the Subsidiaries.

 

    	 

    	 	 	 

    

 

(e)
No Financial Advisor. The Company acknowledges and agrees that each subscriber is acting solely in the capacity of an arm’s
length purchaser with respect to the Securities and the transactions contemplated hereby. The Company further acknowledges that
the undersigned subscriber is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by any subscriber
or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby
and thereby is merely incidental to such subscriber’s purchase of the Securities. The Company further represents to each
subscriber that the Company’s decision to enter into this Subscription Agreement has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(f)
Capitalization and Additional Issuances. The authorized and outstanding capital stock of the Company on a fully diluted
basis as of the date of this Subscription Agreement are set forth in the Company’s SEC Filings. Except as set forth in the
Company’s SEC Filings, there are no options, warrants, or rights to subscribe to, securities, rights, understandings or
obligations convertible into or exchangeable for or giving any right to subscribe for any shares of capital stock or other equity
interest of the Company or any of its subsidiaries. The only officer, director, employee and consultant stock option or stock
incentive plan or similar plan currently in effect or contemplated by the Company are described in the Company’s SEC Filings.
There are no outstanding agreements or preemptive or similar rights affecting the Company’s Common Stock.

 

(g)
Private Placements. Assuming the accuracy of the subscriber’s representations and warranties set forth in Section
2 of this Subscription Agreement, no registration under the Securities Act is required for the offer and sale of the Securities
by the Company to the subscriber as contemplated hereby. None of the Company, its Subsidiaries or any of their affiliates, nor
any Person (as defined below) acting on their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would require registration of the issuance of any of the Securities
under the Securities Act, whether through integration with prior offerings or otherwise, or caused this offering of the Securities
(or any other offering of securities of the Company taken together with this transaction) to require approval of stockholders
of the Company under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of the Principal Market. None of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf will take
any action or steps that would require registration of the issuance of any of the Securities under the Securities Act or cause
the offering of any of the Securities to be integrated with other offerings of securities of the Company.

 

(h)
Investment Company. The Company is not, and is not an affiliate of, and immediately after receipt of payment for the Securities
will not be or be an affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended. The Company shall conduct its business in a manner so that it will not become subject to the Investment Company Act.

 

(i)
Shell Company Status. The Company is not and has never been an issuer identified in Rule 144(i)(1) of the Securities Act.
The Company is, and has been for a period of at least three (3) years, subject to the reporting requirements of Section 13 or
Section 15(d) of the Exchange Act.

 

    	 

    	 	 	 

    

 

(j)
Litigation. Except as set forth in the SEC Filings, there is no action, suit, proceeding, inquiry or investigation before
or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization or body pending or,
to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any
of the Company’s or its Subsidiaries’ officers or directors which is outside of the ordinary course of business or
individually or in the aggregate material to the Company or any of its Subsidiaries. No director, officer or employee of the Company
or any of its Subsidiaries has willfully violated 18 U.S.C. §1519 or engaged in spoliation in reasonable anticipation of
litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director
or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the Securities Act or the Exchange Act. “Governmental Entity”
means any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal, state,
local, municipal, foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental
agency, branch, department, official, or entity and any court or other tribunal), multi-national organization or body; or body
exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority
or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise owned or controlled by a
government or a public international organization or any of the foregoing. “Principal Market” means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE MKT, The NASDAQ Capital Market, The NASDAQ Global Market, The NASDAQ Global Select Market, the New York Stock Exchange, OTCQX,
OTCQB, OTCPK or the OTC Bulletin Board (or any successors to any of the foregoing).

 

(k)
Employee Relations. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or
employs any member of a union. The Company believes that its and its Subsidiaries’ relations with their respective employees
are good. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations respecting
labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect. “Material Adverse Effect” means any material adverse effect on (i) the business, properties,
assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects of the Company and
its Subsidiaries, taken as a whole, (ii) the transactions contemplated hereby or (iii) the authority or ability of the Company
or any of its Subsidiaries to perform any of their respective obligations under any of this Subscription Agreement, the Note or
the Warrant.

 

(l)
Tax Status. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income
and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify
as a passive foreign investment company, as defined in Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

    	 

    	 	 	 

    

 

(m)
Indebtedness and Other Contracts. Except as set forth in the SEC Filings, neither the Company nor any of its Subsidiaries,
(i) has any outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) is in violation of any term of, or in default under, any contract, agreement or
instrument relating to any Indebtedness, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness,
the performance of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect.
For purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication (A) all
indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as the deferred purchase price of property
or services (including, without limitation, “capital leases” in accordance with generally accepted accounting principles)
(other than trade payables entered into in the ordinary course of business), (C) all reimbursement or payment obligations with
respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures
or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or
businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred
as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though
the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale
of such property) required by US GAAP to be disclosed in the Company’s financial statements, (F) all monetary obligations
under any leasing or similar arrangement which, in connection with generally accepted accounting principles, consistently applied
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by)
any mortgage, claim, lien, tax, right of first refusal, pledge, charge, security interest or other encumbrance upon or in any
property or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets
or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect
of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; (y) “Contingent
Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with
respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person
incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability
will be protected (in whole or in part) against loss with respect thereto; and (z) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and any Governmental Entity or any department or agency thereof.

 

(n)
No Undisclosed Events, Liabilities, Developments or Circumstances. Except as set forth in the SEC Filings and except for
the transactions contemplated hereby, no event, liability, development or circumstance has occurred or exists, or is reasonably
expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties,
liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required
to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed with the SEC relating
to an issuance and sale by the Company of its Common Stock and which has not been publicly announced, (ii) could have a material
adverse effect on any subscriber’s investment hereunder or (iii) would reasonably be expected to have a Material Adverse
Effect.

 

(o)
No Disqualification Events. To the Company’s knowledge, none of the Company, any of its predecessors, any affiliated
issuer, any director, executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial
owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor
any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the
time of sale (each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except
for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether
any Issuer Covered Person is subject to a Disqualification Event.

 

    	 

    	 	 	 

    

 

(p)
General Solicitation. None of the Company, any of its affiliates (as defined in Rule 501(b) under the Securities Act) or
any person acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by
means of any form of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement,
article, notice or other communication published in any newspaper, magazine or similar medium or broadcast over television or
radio; and (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 

(q)
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison
pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover
provision under its certificate of incorporation, bylaws or other organizational documents or the laws of the jurisdiction of
its incorporation or otherwise which is or could become applicable to the undersigned subscriber as a result of the transactions
contemplated by the Transaction Documents, including, without limitation, the Company’s issuance of the Securities and any
subscriber’s ownership of the Securities. The Company and its board of directors have taken all necessary action, if any,
in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership
of shares of Common Stock or a change in control of the Company or any of its Subsidiaries. No claim will be made or enforced
by the Company or, to the knowledge of the Company, any other person that any subscriber is an “Acquiring Person”
under any shareholder rights plan or similar plan or arrangement in effect or hereafter adopted by the Company, or that any subscriber
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under this Subscription
Agreement or the Warrant or under any other agreement between the Company and any subscriber.

 

4.
SUBSCRIPTION PROCEDURES

 

The
Company shall have the right to accept or reject this subscription, in whole or in part, and this subscription shall be deemed
to be accepted by the Company only when a copy of the signature page of this Subscription Agreement is executed by the Company.
A prospective Subscriber will only own any Note and become the holder of a Warrant therein upon acceptance of the Subscription
Agreement. A minimum investment (lending commitment) of $500,000 is required. Subscriptions need not be accepted in the order
received by the Company. The undersigned understands and agrees that this subscription may be accepted or rejected by the Company,
in whole or in part in its sole and absolute discretion, and if accepted, the Securities purchased pursuant hereto will be issued
only in the name of the undersigned. The undersigned hereby acknowledges and agrees that, except as otherwise provided by applicable
state law, this Subscription Agreement may not be canceled, revoked or withdrawn, and that this Subscription Agreement and the
documents submitted herewith shall survive (i) changes in the transactions, documents and instruments that are not material, and
(ii) death or disability of the undersigned.

 

5.
INDEMNIFICATION

 

The
Company will indemnify and hold harmless each subscriber and, where applicable, its directors, officers, employees, agents, advisors,
affiliates and shareholders (each, an “Indemnitee”, from and against any and all loss, liability, claim,
damage and expense whatsoever (including, but not limited to, any and all fees, costs and expenses whatsoever reasonably incurred
in investigating, preparing or defending against any claim, lawsuit, administrative proceeding or investigation whether commenced
or threatened) (the “Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising
out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company in any of the
Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company contained in any of the Transaction
Documents or (iii) any cause of action, suit, proceeding or claim brought or made against such Indemnitee by a third party (including
for these purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee
that arises out of or results from (A) the execution, delivery, performance or enforcement of the Transaction Documents, (B) any
transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities,
or (C) the status of such subscriber or holder of the Securities either as an investor in the Company pursuant to the transactions
contemplated hereby or as a party to the Transaction Documents (including, without limitation, as a party in interest or otherwise
in any action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company
may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of
the Indemnified Liabilities which is permissible under applicable law. The amount of any Indemnified Liability shall be net of
(i) any amounts recovered by the Indemnitee in respect of such Indemnified Liability pursuant to any indemnification by or indemnification
agreement with any third party (net of any costs of recovery), (ii) any insurance proceeds actually received by the Indemnity
in respect of the Indemnified Liability (net of any deductible amounts or associated incremental premiums that the Indemnitee
reasonably expects to incur as a result of the claim) and (iii) any tax benefit to the Indemnitee, to the extent such tax benefit
relates solely to such Indemnified Liability. Notwithstanding anything contained herein to the contrary, an Indemnitee shall not
be required to seek to recover any amounts, proceeds or benefits referred to in the immediately preceding sentence as a condition
precedent to seeking indemnification from the Company pursuant to this Section 5.

 

    	 

    	 	 	 

    

 

6.
RESTRICTIONS OF TRANSFER

 

(a)
Legends. The subscriber understands that the Securities have been issued (or will be issued in the case of the Warrant Shares)
pursuant to an exemption from registration or qualification under the Securities Act and applicable state securities laws, and
except as set forth in Section 6(b) below, the Securities shall bear any legend as required by the “blue sky” laws
of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer
of such stock certificates):

 

NEITHER
THIS SECURITY NOR THE SECURITIES UNDERLYING THIS SECURITY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2)
AN OPINION OF HOLDER’S COUNSEL, IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE
SECURITIES LAWS.

 

(b)
Removal of Legends. Certificates evidencing Securities shall not be required to contain the legend set forth in Section 6(a) above
or any other legend (i) while a registration statement covering the resale of such Securities is effective under the Securities
Act, (ii) following any sale of such Securities pursuant to Rule 144 under the Securities Act (assuming the transferor is not
an affiliate of the Company), (iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144 under the
Securities Act (provided that the Investor provides the Company with reasonable assurances that such Securities are eligible for
sale, assignment or transfer under Rule 144 which shall not include an opinion of counsel), (iv) in connection with a sale, assignment
or other transfer (other than under Rule 144), provided that such subscriber provides the Company with an opinion of counsel to
such subscriber, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities may be
made without registration under the applicable requirements of the Securities Act or (v) if such legend is not required under
applicable requirements of the Securities Act (including, without limitation, controlling judicial interpretations and pronouncements
issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later than three (3) Business
Days following the delivery by the subscriber to the Company or the transfer agent (with notice to the Company) of a legended
certificate representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form
necessary to affect the reissuance and/or transfer, if applicable), as directed by such subscriber, either: (A) provided that
the Company’s transfer agent is participating in the DTC Fast Automated Securities Transfer Program and such Securities
are Warrant Shares, credit the aggregate number of shares of Common Stock to which such subscriber shall be entitled to such subscriber’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s
transfer agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver at the Company’s
expense (via reputable overnight courier) to such subscriber, a certificate representing such Securities that is free from all
restrictive and other legends, registered in the name of such subscriber or its designee (the date by which such credit is so
required to be made to the balance account of such subscriber’s or such subscriber’s nominee with DTC or such certificate
is required to be delivered to such subscriber pursuant to the foregoing is referred to herein as the “Required Delivery
Date”). If the Company fails to (i) issue and deliver (or cause to be delivered) to the subscriber by the Required
Delivery Date a certificate representing Warrant Shares so delivered to the Company by such subscriber that is free from all restrictive
and other legends or (ii) credit the balance account of such subscriber’s or such subscriber’s nominee with DTC for
such number of Warrant Shares so delivered to the Company, and if after such date the subscriber is required to effect a Buy-In
(as defined in the Warrant), then, in addition to all other remedies available to such subscriber, the Company shall pay in cash
to such subscriber the amount set forth in Section 2(d)(iv) of the Warrant.

 

    	 

    	 	 	 

    

 

7.
SOCIAL SECURITY OR TAXPAYER IDENTIFICATION NUMBER

 

The
undersigned, under penalties of perjury, certifies that the taxpayer identification number or Social Security number shown hereon
is true and correct and that the undersigned is not subject to any withholding either because the undersigned has not been notified
that the undersigned is subject to backup withholding as a result of failure to report all interest or dividends or because the
Internal Revenue Service has notified the undersigned that the undersigned is no longer subject to backup withholding.

 

8.
FURTHER COVENANTS

 

(a)
Securities Laws Disclosure; Publicity. If required under the Exchange Act, the Company shall within four (4) Business Days
after this Subscription Agreement has been executed, file a Current Report on Form 8-K with the SEC, including the Transaction
Documents as exhibits thereto (the “8-K Filing”). From and after the filing of the 8-K Filing, the Company
shall have publicly disclosed all material, non-public information delivered to any of the subscribers by the Company or any of
its Subsidiaries, or any of their respective officers, directors, employees or agents. No subscriber shall issue any such press
release or otherwise make any such public statement without the prior consent of the Company, which consent shall not unreasonably
be withheld.

 

(b)
Integration. The Company shall not, and shall use its best efforts to ensure that no affiliate of the Company shall, after
the date hereof, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security other than additional
notes and warrants issued hereunder that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities to the subscribers.

 

    	 

    	 	 	 

    

 

(c)
Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Warrant in such amount as may be required to fulfill its obligations in full under the Warrant. In the event that
at any time the then authorized shares of Common Stock are insufficient for the Company to satisfy its obligations in full under
the Warrant, the Company shall promptly take such actions as may be required to increase the number of authorized shares.

 

(d)
Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated hereby,
the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any subscriber or its
agents or counsel with any information that the Company believes constitutes material non-public information. The Company understands
and confirms that each subscriber shall be relying on the foregoing covenant in effecting transactions in securities of the Company.
In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their
respective officers, directors, affiliates, employees or agents, on the one hand, and the subscriber or any of its affiliates,
on the other hand, shall terminate.

 

(e)
Accounts and Records; Inspections. The Company shall keep true records and books of account in which full, true and correct
entries will be made of all dealings or transactions in relation to the business and affairs of the Company and its subsidiaries
in accordance with GAAP applied on a consistent basis. The Company shall permit each holder of any Securities or any of such holder’s
officers, employees or representatives during regular business hours of the Company, upon reasonable notice and as often as such
holder may reasonably request, to visit and inspect the offices and properties of the Company and its subsidiaries and to make
extracts or copies of the books, accounts and records of the Company or its subsidiaries at such holder’s expense. Nothing
contained in this Section shall be construed to limit any rights which a holder of any Securities may otherwise have with respect
to the books and records of the Company and its Subsidiaries, to inspect its properties or to discuss its affairs, finances and
accounts.

 

9.
GENERAL PROVISIONS

 

	 	(a)	This
    Subscription Agreement will be governed by and construed in accordance with the substantive laws of the State of Delaware
    without regard thereof relating to conflicts of laws.
	 	 	 
	 	(b)	This
    Subscription Agreement, together with the Note, the Security Agreement and the Warrant constitutes the entire agreement between
    the parties with respect to the subject matter and supersedes any prior agreements between the parties. This Subscription
    Agreement may be amended only by a writing executed by the parties.
	 	 	 
	 	(c)	The
    Note or Warrant will be assigned or transferred only in accordance with applicable law and the terms of this Subscription
    Agreement and the Note or Warrant, as the case may be.
	 	 	 
	 	(d)	This
    Subscription Agreement will survive the undersigned’s death or dissolution and will be binding upon the undersigned’s
    successors, heirs, assignees, representatives and distributees.
	 	 	 
	 	(e)	If
    any provision of this Subscription Agreement is invalid or unenforceable under any applicable law, then such provision shall
    be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified only to the extent necessary
    to conform to such applicable law. Any provision hereof that may be held invalid or unenforceable under any applicable law
    shall not affect the validity or enforceability of any other provisions hereof, and to this extent the provisions hereof shall
    be severable.

 

    	 

    	 	 	 

    

 

	 	(f)	The
    parties’ representations and warranties in the Transaction Documents shall survive the execution and delivery of such
    Transaction Documents.
	 	 	 
	 	(g)	Within
    five days after receipt of a request from the Company, the undersigned hereby agrees to provide such reasonable information
    and to execute and deliver such documents as may be reasonably necessary to comply with any and all laws to which the Company
    is subject.
	 	 	 
	 	(h)	The
    Company shall reimburse the reasonable, documented legal fees incurred by the Subscribers in preparing and negotiating the
    Transaction Documents; provided that, in no event shall the Company reimburse more than $10,000 in the aggregate.

 

10.
SUBSCRIPTION

 

The
undersigned hereby subscribes for a One Million Dollar ($1,000,000) Note to be issued by the Company, the Warrant and 34,000 Warrant
Shares. The undersigned understands that this subscription is and shall be irrevocable after passage of any right of rescission
required by applicable state law.

 

1.
The Subscriber is [  ]/ is not [X] please check as appropriate) a “benefit plan investor.”

 

A
“benefit plan investor” is a plan described in 19 C.F.R. Section 2510.3-101(f)(2) issued by the United States
Department of Labor i.e., any employee benefit plan, whether or not subject to Title I of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”), or other plan subject to the prohibited transaction provisions of Section
4975 of the Internal Revenue Code of 1986, as amended (“Code”)) or an entity whose assets are deemed “plan
assets” for purposes of Title I of ERISA and Section 4975 of the code.

 

If
the Subscriber is a benefit plan investor (a “Plan”), it is so because it is (please check as appropriate):

 

[  ] an employee benefit plan within
the meaning of and subject to Title I or ERISA (an “ERISA Plan”); or

 

[  ]
an entity whose assets are deemed to constitute “plan assets” for purposes of Title I of ERISA and Section 4975 of
the Code (also an “ERISA Plan”).

 

2.
The Subscriber is [  ]/ is not [X] (please check as appropriate) exempt from U.S. federal income tax under the Code.
If the Subscriber is tax-exempt, please attach to this Agreement a copy of the Determination Letter from the Internal Revenue
Service regarding the Subscriber’s tax-exempt status.

 

3.
The Subscriber is [  ]/ is not [X] (please check as appropriate) a “venture capital operating company”
as such term is defined in 29 CFR Section 2510.3-101.

 

    	 

    	 	 	 

    

 

4.
Does the undersigned grant permission to the Company to identify the undersigned by name as an investor in the Company to prospective
investors in the Company.

 

[X] Yes

 

[  ]
No

 

The
undersigned represents that the undersigned has read this Subscription Agreement.

 

The
wire instructions in connection with the subscription for the Note are as follows:

 

Bank:

 

ABA
#:

 

Account
Name:

 

Account
#:

 

(The
remainder of this page is intentionally left blank)

 

    	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the Company has executed this Subscription Agreement as of the 11th day of December, 2015, at _______________,
_______________.

                           (City)                          (State)

 

	 	COMPANY:
	 	 
	 	PROPHASE
    LABS, INC. 
	 	 
	 	By:	/s/ Ted Karkus
	 	Name:	Ted
    Karkus
	 	Title:	Chief
    Executive Officer

 

    	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Subscription Agreement as of the _____ day of ___________, 201_, at _______________,
_______________.

                                                      (City)                           (State)

 

BUSINESS
ENTITIES

 

	 	 
	Name
    of Business Entity	 
	 	 	 
	TIN	 	 
	 	 	 
	By:
    	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:
    	 	 
	 	 	 
	 	 
	State
    of Organization	 
	 	 
	 	 
	Business
    Address	 
	 	 
	 	 
	Telephone
    Number	 
	 	 
	 	 
	Facsimile
    Number	 
	 	 
	 	 
	E-mail
    Address	 

 

    	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Subscription Agreement as of the _____ day of ___________, 201_, at _______________,
_______________.

                                                     (City)                          (State)

 

TRUSTS
OR PLANS

 

	 	 
	Name
    of Trust or Plan	 
	 	 	 
	TIN
    	 	 
	 	 	 
	By:
    	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:
    	 	 
	 	 
	 	 
	State
    of Formation, if applicable	 
	 	 
	 	 
	Plan
    Address	 
	 	 
	 	 
	Telephone
    Number	 
	 	 
	 	 
	Facsimile
    Number	 
	 	 
	 	 
	E-mail
    Address	 

 

    	 

    	 	 	 

    

 

IN
WITNESS WHEREROF, the undersigned has executed this Subscription Agreement as of the 11th day of December, 2015, at ____________________,
_________________.

(City)                                 
(State)

 

INDIVIDUALS

 

	/s/
    John E. Ligums, Jr.	 	 
	Signature
    of Prospective Investor	 	Signature
    of Co-Owner or Spouse (if applicable)
	 	 	 
	SSN:	 	 	SSN:	 
	 	 	 
	 	 	 
	Typed
    or printed FULL Name of Prospective Investor	 	Typed
    or Printed FULL name of Co-Owner or Spouse (if applicable)
	 	 	 
	State
    of Residence	 	State
    of Residence
	 	 	 
	 	 	 
	Employer	 	Employer
	 	 	 
	 	 	 
	Occupation	 	Occupation
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Business/Home
    Address	 	Business/Home
    Address
	 	 	 
	 	 	 
	Facsimile
    Number	 	Facsimile
    Number
	 	 	 
	 	 	 
	E-mail
    Address	 	E-mail
    Address

 

Send
correspondence to

 

	 	Home	 	 	Office	 	 

 

    	 

    	 	 	 

    

 

Execution
Version

 

ProPhase
Labs, Inc. 

12%
Secured Promissory Note – Series A

and
Warrant

 

SUBSCRIPTION
AGREEMENT

 

1.
SUBSCRIPTION

 

The
undersigned subscriber hereby subscribes for a Five Hundred Thousand Dollar ($500,000) 12% Secured Promissory Note – Series
A due June 15, 2017 (the “Note”), together with the Warrant acquired simultaneously therewith (the “Warrant”),
from ProPhase Labs, Inc. (the “Company”), a Delaware corporation having its principal place of
business at 621 N. Shady Retreat Road, Doylestown PA 18901. The undersigned understands the Note is one of a series of 12% Secured
Promissory Notes- Series A in the aggregate amount of up to $3,000,000 and that this subscription may be accepted or rejected
in whole or in part by the Company in its sole discretion. The Warrant is exercisable for shares of the Company’s common
stock, par value $0.0005 per share (the “Common Stock”). The number of shares issuable upon exercise
of the Warrant are collectively referred to herein as “Warrant Shares”. The Note, the Warrant and the
Warrant Shares are sometimes collectively referred to herein as the “Securities”. This subscription
is and shall be irrevocable (after passage of any right of rescission required by applicable state law) unless the Company for
any reason rejects this subscription. Unless otherwise defined herein, all capitalized terms used herein have the respective meanings
given to such terms in the Note, the Warrant or the Security Agreement granted in favor of all Series A Note holders simultaneously
with the issuance of the Note.

 

2.
REPRESENTATIONS AND WARRANTIES OF THE SUBSCRIBER

 

The
undersigned subscriber hereby represents and warrants to the Company that the following statements are true and correct as of
the date hereof:

 

(a)
The undersigned is an accredited investor within the meaning of Rule 501 of Regulation D promulgated under the Securities Act
of 1933, as amended (the “Securities Act”). The undersigned is an accredited investor because he, she
or it is (please check each applicable category):

 

	 	[  ]	 	i)	a
    bank is defined in Section 3(a)(2) of the 1933 Act;
	 	 	 	 	 
	 	[  ] 	 	ii)	a
    savings and loan association or other institution as defined in Section 3(a)(5)(A) of the 1933 Act, whether acting in its
    individual or fiduciary capacity;
	 	 	 	 	 
	 	[  ]	 	iii)	a
    broker or dealer registered pursuant to Section 15 of the Securities Exchange Act of 1934, as amended;
	 	 	 	 	 
	 	[  ]	 	iv)	an
    insurance company as defined in Section 2(13) of the 1933 Act;
	 	 	 	 	 
	 	[  ] 	 	v)	an
    investment company registered under the Investment Company Act of 1940, as amended (the “1940 Act”);

 

    	- 1 -

     

    

 

	 	[  ] 	 	vi)	a
    business development company, as defined in Section 2(a)(48) of the 1940 Act;
	 	 	 	 	 
	 	[  ]	 	vii)	a
    Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small
    Business Investment Act of 1958;
	 	 	 	 	 
	 	[  ]	 	viii)	any
    plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its
    political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[  ]	 	ix)	any
    employee benefits plan within the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision
    is made by a plan fiduciary, as defined in Section 3(21) of such Act, which is either a bank, savings and loan association,
    insurance company, or registered investment advisor, or if the employee benefit plan has total assets in excess of $5,000,000
    or, if a self-directed plan, with the investment decisions made solely by persons that are accredited investors;
	 	 	 	 	 
	 	[  ] 	 	x)	a
    private business development company, as defined in section 202(a)(22) of the Advisers Act;
	 	 	 	 	 
	 	[  ] 	 	xi)	an
    organization described in Section 501(c)(3) of the Internal Revenue Code of 1986 (the “Code”), not
    formed for the specific purpose of acquiring a Unit, and which has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[  ] 	 	xii)	a
    corporation, a Massachusetts or similar business trust, or a partnership, which entity was not formed for the specific purpose
    of acquiring a Unit, and which has total assets in excess of $5,000,000;
	 	 	 	 	 
	 	[X]	 	xiii)	a
    natural person whose individual net worth, or net worth together with that person’s spouse, exceeds $1,000,000 (excluding
    from the calculation the value of the undersigned’s primary residence but including any indebtedness secured by that
    residence that is in excess of that residence’s value);
	 	 	 	 	 
	 	[X]	 	xiv)	a
    natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with
    that person’s spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same
    income level in the current year;
	 	 	 	 	 
	 	[  ]	 	xv)	a
    trust with assets in excess of $5,000,000, not formed for the specific purpose of acquiring a Unit, whose purchase of the
    Note and Warrant is directed by a sophisticated person as described in Rule 506(b)(2)(ii) under the 1933 Act;
	 	 	 	 	 
	 	[  ]	 	xvi)	any
    director, executive officer, or principal of the Company; and/or
	 	 	 	 	 
	 	[  ] 	 	xvii)
    	any
    entity each of the equity owners of which satisfies one or more of the above conditions (i.e., are “accredited investors”).

 

    	- 2 -

     

    

 

(b)
The undersigned has evaluated carefully the undersigned’s financial resources and investment position and the risks associated
with this investment, and is able to bear the substantial economic risks of the undersigned’s investment in the Securities
for an indefinite period of time, can afford to hold the Note until maturity, and can afford a complete loss of the undersigned’s
investment in the Securities.

 

(c)
The undersigned either has such knowledge and experience in financial, tax and business matters or has received professional guidance
with respect to this investment, and is either alone, or with those providing such guidance, capable of evaluating the merits
and risks of an investment in the Securities and to make an informed investment decision with respect thereto.

 

(d)
The undersigned has been given the opportunity (i) to obtain information and to examine all documents relating to the Note and
Warrant, the Company and its business, (ii) to ask questions of, and to receive answers from, the management of the Company concerning
the Company, the Company’s business, and the terms and conditions of this investment, and (iii) to obtain any additional
information, to the extent the Company possesses such information or could acquire such information without unreasonable effort
or expense, necessary to verify the accuracy of any information previously furnished. All such questions have been answered to
the undersigned’s full satisfaction, and the undersigned has not relied on oral representations or oral information furnished
to the undersigned in connection with the purchase of the Securities which were in any way inconsistent with the Company’s
filings with the Securities Exchange Commission (“SEC Filings”).

 

(e)
The undersigned has had an opportunity to read and understand the provisions of this Subscription Agreement, to consult with the
undersigned’s adviser(s) or counsel regarding the operation and consequences of those provisions and has considered the
effect of those provisions on the undersigned.

 

(f)
No representations have been made to the undersigned concerning projected results, expected yields or any other prospective information
concerning operation of the Company other than those contained in the SEC Filings and accompanying exhibits.

 

(g)
The undersigned is acquiring the Securities for the undersigned’s own account or for the undersigned’s own account
as fiduciary of either an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as
amended (“ERISA”) for investment and not with a view to or for resale, in connection with public offering or distribution
of the Securities and without any present intention to sell the Securities at any particular event or circumstance. The undersigned
has no agreement or other arrangement with any person to sell, transfer or pledge all or any part of the Securities subscribed
for that would guarantee the undersigned any profit or protect against any loss with respect to the Securities.

 

(h)
The undersigned has no present obligation, indebtedness, or commitment, nor is any circumstance in existence that will compel
the undersigned to secure funds by the sale of the Securities, nor is the undersigned a party to any plan or undertaking that
would require or contemplate that proceeds from the sale of all or a part of the Securities be utilized in connection therewith.
The undersigned does not intend or anticipate that the undersigned will rely on this investment as a source of income.

 

(i)
The undersigned represents that the undersigned’s investment in the Securities involves a high degree of risk. The undersigned
takes full cognizance of, and understands such risks and has obtained sufficient information to evaluate the Company and the merits
and risks of an investment in the Securities.

 

    	- 3 -

     

    

 

(j)
The undersigned, if a corporation, partnership, trust or other entity, represents and warrants that it, or each of its equity
owners, was not organized for the specific purpose of acquiring the Securities and has other investments or business activities
or will make other investments or engage in other business activities, unless the undersigned has indicated the contrary to the
Company and specified the number of beneficial owners thereof, and the Company has consented in writing thereto. The undersigned,
if an individual, represents and warrants that the undersigned is not acquiring the Securities as a nominee, trustee, agent, or
representative for any other person, unless the undersigned has indicated the contrary to the Company and specified the number
of beneficial owners thereof, and the Company has consented in writing thereto.

 

(k)
None of the Securities offered under by this Subscription Agreement have been registered under the Securities Act or the securities
laws of certain states and are being offered and sold in reliance on exemptions from the registration requirements of the Securities
Act and such laws. The Securities, and any beneficial interest therein, are subject to restrictions on transferability and resale
and may not be transferred or resold, in whole or in part, except as permitted under the Securities Act and such laws pursuant
to registration or exemption therefrom. The Securities have not been approved or disapproved by the Securities and Exchange Commission
(the “SEC”), any state securities commission, or other regulatory authority, or have any of the foregoing
authorities passed on or endorsed the merits of the offering of the Securities or the accuracy or adequacy of the SEC Filings
with respect to such offering. Any representation to the contrary is unlawful. The undersigned understands that the Company is
under no obligation to register the Securities under the Securities Act. Each Subscriber must bear the economic risk of an investment
in the Securities, and the Securities may not be resold unless subsequently registered under applicable securities laws or unless
an exemption from such registration is available.

 

(l)
The undersigned confirms that the Securities were not offered to the undersigned by any means of general solicitation or general
advertising.

 

(m)
The undersigned’s representations and warranties in this Section 2 are true and correct as of the date hereof and shall
survive such delivery.

 

(n)
The undersigned is authorized and has full right and power to subscribe for the Securities and to perform the undersigned’s
obligations pursuant to the provisions hereof, and the person signing this Subscription Agreement and any other instrument executed
and delivered herewith on behalf of the prospective investor has been duly authorized by such entity and has full power and authority
to do so.

 

(o)
If the undersigned is an employee benefit plan subject to ERISA, then the undersigned acknowledges that the undersigned has been
informed of and understands the investment objectives and policies of, and the investment strategies that may be pursued by, the
Company and represents that the undersigned’s investment in the Securities (i) is permissible under the documents and instruments
governing such plan, (ii) satisfies the diversification requirements of section 404(a)(1)(C) of ERISA, (iii) is prudent considering
all the facts and circumstances, including the fact that there is not expected to by any public market for the disposition of
the Securities and (iv) is not a “prohibited transaction” within the meaning of section 406 of ERISA.

 

(p)
The undersigned understands and acknowledges that any projections regarding the business or finances of the Company contained
in the SEC Filings or any written materials received from the Company by the undersigned are based on numerous assumptions relying
on certain factors over which the Company has no control, and accordingly these projections are not guaranteed or warranted and
no assurance can be given to the undersigned about the returns that may be realized by an investment in the Securities. The undersigned
acknowledges that any reliance on any projections contained in the SEC Filings or such written materials shall be solely at the
undersigned’s risk and the undersigned is expected to undertake its own due diligence, inspections, investigations and assessments
as to the feasibility of the business of the Company.

 

    	- 4 -

     

    

 

(q)
The undersigned understands that the representations contained in this Subscription Agreement are made for the purpose of qualifying
the undersigned, or the entity for which the undersigned is acting, as a suitable investor for the purpose of establishing exemptions
from the registration or qualification provisions of the Securities Act and the securities laws of certain states for the offering
and sale of the Securities.

 

(r)
The undersigned is either a citizen of the United States of America (including an entity organized under the laws of any of the
50 states of the United States) or taxed as a resident of the United States of America for purposes of federal income tax.

 

(s)
The undersigned represents and warrants that its investment was not directly or indirectly derived from illegal activities, including
any activities that would violate United States Federal or State laws or any laws and regulations of other countries.

 

(t)
The undersigned acknowledges that United States Federal law, regulations and Executive Orders administered by the U.S. Treasury
Department’s Office of Foreign Assets Control (“OFAC”) prohibit the Company from, among other
things, engaging in transactions with, and the provision of services to, persons on the list of Specially Designated Nationals
and Blocked Persons and foreign countries and territories subject to U.S. sanctions administered by OFAC (together, the “OFAC
Maintained Sanctions”).

 

(u)
The undersigned represents and warrants that neither the undersigned, nor any person controlling, controlled by, or under common
control with, the undersigned, nor, to the best of the undersigned’s knowledge, any person having a beneficial interest
in the undersigned, or for whom the undersigned is acting as agent or nominee in connection with this investment, (i) is a country,
territory, person or entity subject to an OFAC Maintained Sanction or (ii) is a foreign shell bank as that term is defined by
the U.S. Treasury Department.

 

(v)
The undersigned represents and warrants that, if it is an entity designated as a “financial institution” in the USA
PATRIOT Act of 2001 (generally including banks, trust companies, thrift institutions, agencies or branches of foreign banks, investment
bankers, broker-dealers, investment companies, insurance companies, investment advisers, futures commission merchants, commodity
trading advisors, and commodity pool operators), it has implemented and enforces an anti-money laundering program (“AMLP”)
that is compliant with the USA PATRIOT Act of 2001 and that its AMLP, at a minimum:

 

	 	● 	Maintains
    and enforces a customer identification program in accordance with applicable regulatory requirements under Section 326 of
    the USA PATRIOT Act of 2001;
	 	 	 
	 	●	For
    each investor, client, customer, and principal, verifies and documents its investor, client, customer or principal nor any
    person that controls, is controlled by or is under common control with any investor, client, customer or principal (1) is
    a country, territory, person or entity subject to an OFAC Maintained Sanction, or (2) is a foreign shell bank as that term
    is defined by the U.S. Treasury Department;

 

    	- 5 -

     

    

 

	 	●	Includes
    reasonable internal procedures and controls to detect and report suspicious activities;
	 	 	 
	 	●	Designates
    a compliance officer for anti-money laundering responsibilities;
	 	 	 
	 	● 	Provides
    on-going employee training with respect to anti-money laundering policies and procedures; and
	 	 	 
	 	● 	Includes
    an independent audit function to test its AMLP.

 

(w)
The undersigned acknowledges and agrees that the Company, in complying with anti-money laundering statutes, regulations and goals,
may file voluntarily and/or as required by law suspicious activity reports (“SARs”) or any other information
with governmental and law enforcement agencies that identify transactions and activities that the Company or its agents reasonably
determine to be suspicious, or is otherwise required by law.

 

(x)
The undersigned acknowledges that the Company is prohibited by law from disclosing to third parties, including the undersigned,
any filing or the substance of any SAR.

 

(y)
The undersigned confirms that all information and documentation provided to the Company, including, but not limited to, all information
regarding the undersigned’s identity, business, investment objectives, and source of the funds to be invested in the Company,
is true and correct.

 

(z)
The undersigned represents and warrants that he/she/it is [  ]/ is not [X] (please check one) a senior foreign
political figure, or an immediate family member or close associate of a senior foreign political figure within the meaning of
the USA PATRIOT Act of 2001 and that the undersigned is [  ]/ is not [X] (please check one) making an investment
in the Company on behalf of such a person.

 

(aa)
The undersigned acknowledges that the Company may not accept any investment from the undersigned if the undersigned cannot truthfully
make the representations set forth in any of the preceding subsections.

 

3.
REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

The
Company hereby represents and warrants to the undersigned subscriber that the following statements are true and correct:

 

(a)
Organization and Qualification. The Company is a corporation duly organized, validly existing and in good standing under
the laws of its state of incorporation. The Company is duly qualified to do business, and is in good standing in the states required
due to (a) the ownership or lease of real or personal property for use in the operation of the Company’s business or (b)
the nature of the business conducted by the Company except where failure to do so would not have a material adverse effect on
the Company. The Company has all requisite power, right and authority to own, operate and lease its properties and assets, to
carry on its business as now conducted, to execute, deliver and perform its obligations under this Subscription Agreement, the
Note, the Warrant and the security agreement executed in connection with the Note (collectively, the “Transaction
Documents”), and to carry out the transactions contemplated hereby and thereby. All actions on the part of the Company
and its officers and directors necessary for the authorization, execution, delivery and performance of the Transaction Documents,
the consummation of the transactions contemplated hereby and thereby, and the performance of all of the Company’s obligations
under Transaction Documents have been taken or will be taken prior to the closing. Each of the Transaction Documents have been
duly executed and delivered by the Company, and each of the Transaction Documents constitutes a legal, valid and binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as may be limited by bankruptcy, reorganization,
insolvency, moratorium and similar laws of general application relating to or affecting the enforcement of rights of creditors,
and except as enforceability of the obligations hereunder are subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or law).

 

    	- 6 -

     

    

 

(b)
Issuance of Securities. The Securities to be issued to the undersigned investor pursuant to this Subscription Agreement
and the Warrant, as applicable, when issued and delivered in accordance with the terms of this Subscription Agreement and the
Warrant, as applicable, will be duly and validly issued and will be fully paid and non-assessable.

 

(c)
Authorization; Enforcement. The execution, delivery and performance of the Transaction Documents by the Company, and the
consummation of the transactions contemplated hereby and thereby, will not (a) constitute a violation (with or without the giving
of notice or lapse of time, or both) of any provision of any law or any judgment, decree, order, regulation or rule of any court,
agency or other governmental authority applicable to the Company or any of its Subsidiaries (as defined below), including, without
limitation, the rules of the Principal Market (defined below), (b) require any consent, approval or authorization of, or declaration,
filing or registration with, any person, including, without limitation, any shareholder of the Company and/or the Principal Market,
(c) result in a default (with or without the giving of notice or lapse of time, or both) under, acceleration or termination of,
or the creation in any party of the right to accelerate, terminate, modify or cancel, any agreement, lease, note or other restriction,
encumbrance, obligation or liability to which the Company or any of its Subsidiaries is a party or by which it is bound or to
which any assets of the Company or any of its Subsidiaries are subject, (d) result in the creation of any lien or encumbrance
upon the assets of the Company or any of its Subsidiaries, or upon any shares of Common Stock, preferred stock or other securities
of the Company or any of its Subsidiaries except for liens in favor of the holders of the Notes created by the Security Agreement,
(e) conflict with or result in a breach of or constitute a default under any provision of the certificate of incorporation or
bylaws of the Company or any of its Subsidiaries, or (f) invalidate or adversely affect any permit, license, authorization or
status used in the conduct of the business of the Company and its Subsidiaries.

 

(d)
SEC Filings. The Company is subject to, and in full compliance with, the reporting requirements of Section 13 or 15(d)
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Company has made available
to each subscriber through the EDGAR system true and complete copies of the Company’s filings for the prior two full fiscal
years plus any interim period (collectively, the “SEC Filings”). Since December 31, 2013, the SEC Filings,
when they were filed with the SEC (or, if any amendment with respect to any such document was filed, when such amendment was filed),
complied in all material respects with the applicable requirements of the Exchange Act and the rules and regulations thereunder
and did not, as of such date, contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading. All reports and statements required to be filed by the Company under the Exchange Act have been filed, together with
all exhibits required to be filed therewith. The Company and each of its direct and indirect subsidiaries, if any (collectively,
the “Subsidiaries”), are engaged in all material respects only in the business described in the SEC
Filings, and the SEC Filings contain a complete and accurate description in all material respects of the business of the Company
and the Subsidiaries.

 

    	- 7 -

     

    

 

(e)
No Financial Advisor. The Company acknowledges and agrees that each subscriber is acting solely in the capacity of an arm’s
length purchaser with respect to the Securities and the transactions contemplated hereby. The Company further acknowledges that
the undersigned subscriber is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with
respect to the Transaction Documents and the transactions contemplated hereby and thereby and any advice given by any subscriber
or any of its representatives or agents in connection with the Transaction Documents and the transactions contemplated hereby
and thereby is merely incidental to such subscriber’s purchase of the Securities. The Company further represents to each
subscriber that the Company’s decision to enter into this Subscription Agreement has been based solely on the independent
evaluation of the transactions contemplated hereby by the Company and its representatives.

 

(f)
Capitalization and Additional Issuances. The authorized and outstanding capital stock of the Company on a fully diluted
basis as of the date of this Subscription Agreement are set forth in the Company’s SEC Filings. Except as set forth in the
Company’s SEC Filings, there are no options, warrants, or rights to subscribe to, securities, rights, understandings or
obligations convertible into or exchangeable for or giving any right to subscribe for any shares of capital stock or other equity
interest of the Company or any of its subsidiaries. The only officer, director, employee and consultant stock option or stock
incentive plan or similar plan currently in effect or contemplated by the Company are described in the Company’s SEC Filings.
There are no outstanding agreements or preemptive or similar rights affecting the Company’s Common Stock.

 

(g)
Private Placements. Assuming the accuracy of the subscriber’s representations and warranties set forth in Section
2 of this Subscription Agreement, no registration under the Securities Act is required for the offer and sale of the Securities
by the Company to the subscriber as contemplated hereby. None of the Company, its Subsidiaries or any of their affiliates, nor
any Person (as defined below) acting on their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would require registration of the issuance of any of the Securities
under the Securities Act, whether through integration with prior offerings or otherwise, or caused this offering of the Securities
(or any other offering of securities of the Company taken together with this transaction) to require approval of stockholders
of the Company under any applicable stockholder approval provisions, including, without limitation, under the rules and regulations
of the Principal Market. None of the Company, its Subsidiaries, their affiliates nor any Person acting on their behalf will take
any action or steps that would require registration of the issuance of any of the Securities under the Securities Act or cause
the offering of any of the Securities to be integrated with other offerings of securities of the Company.

 

(h)
Investment Company. The Company is not, and is not an affiliate of, and immediately after receipt of payment for the Securities
will not be or be an affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended. The Company shall conduct its business in a manner so that it will not become subject to the Investment Company Act.

 

(i)
Shell Company Status. The Company is not and has never been an issuer identified in Rule 144(i)(1) of the Securities Act.
The Company is, and has been for a period of at least three (3) years, subject to the reporting requirements of Section 13 or
Section 15(d) of the Exchange Act.

 

    	- 8 -

     

    

 

(j)
Litigation. Except as set forth in the SEC Filings, there is no action, suit, proceeding, inquiry or investigation before
or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization or body pending or,
to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Common Stock or any
of the Company’s or its Subsidiaries’ officers or directors which is outside of the ordinary course of business or
individually or in the aggregate material to the Company or any of its Subsidiaries. No director, officer or employee of the Company
or any of its Subsidiaries has willfully violated 18 U.S.C. §1519 or engaged in spoliation in reasonable anticipation of
litigation. Without limitation of the foregoing, there has not been, and to the knowledge of the Company, there is not pending
or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries or any current or former director
or officer of the Company or any of its Subsidiaries. The SEC has not issued any stop order or other order suspending the effectiveness
of any registration statement filed by the Company under the Securities Act or the Exchange Act. “Governmental Entity”
means any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal, state,
local, municipal, foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental
agency, branch, department, official, or entity and any court or other tribunal), multi-national organization or body; or body
exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority
or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise owned or controlled by a
government or a public international organization or any of the foregoing. “Principal Market” means
any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the
NYSE MKT, The NASDAQ Capital Market, The NASDAQ Global Market, The NASDAQ Global Select Market, the New York Stock Exchange, OTCQX,
OTCQB, OTCPK or the OTC Bulletin Board (or any successors to any of the foregoing).

 

(k)
Employee Relations. Neither the Company nor any of its Subsidiaries is a party to any collective bargaining agreement or
employs any member of a union. The Company believes that its and its Subsidiaries’ relations with their respective employees
are good. The Company and its Subsidiaries are in compliance with all federal, state, local and foreign laws and regulations respecting
labor, employment and employment practices and benefits, terms and conditions of employment and wages and hours, except where
failure to be in compliance would not, either individually or in the aggregate, reasonably be expected to result in a Material
Adverse Effect. “Material Adverse Effect” means any material adverse effect on (i) the business, properties,
assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects of the Company and
its Subsidiaries, taken as a whole, (ii) the transactions contemplated hereby or (iii) the authority or ability of the Company
or any of its Subsidiaries to perform any of their respective obligations under any of this Subscription Agreement, the Note or
the Warrant.

 

(l)
Tax Status. The Company and each of its Subsidiaries (i) has timely made or filed all foreign, federal and state income
and all other tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has timely paid
all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns,
reports and declarations, except those being contested in good faith and (iii) has set aside on its books provision reasonably
adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company and its Subsidiaries know of no basis for any such claim. The Company is not operated in such a manner as to qualify
as a passive foreign investment company, as defined in Section 1297 of the U.S. Internal Revenue Code of 1986, as amended.

 

    	- 9 -

     

    

 

(m)
Indebtedness and Other Contracts. Except as set forth in the SEC Filings, neither the Company nor any of its Subsidiaries,
(i) has any outstanding Indebtedness (as defined below), (ii) is a party to any contract, agreement or instrument, the violation
of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be expected
to result in a Material Adverse Effect, (iii) is in violation of any term of, or in default under, any contract, agreement or
instrument relating to any Indebtedness, or (iv) is a party to any contract, agreement or instrument relating to any Indebtedness,
the performance of which, in the judgment of the Company’s officers, has or is expected to have a Material Adverse Effect.
For purposes of this Agreement: (x) “Indebtedness” of any Person means, without duplication (A) all
indebtedness for borrowed money, (B) all obligations issued, undertaken or assumed as the deferred purchase price of property
or services (including, without limitation, “capital leases” in accordance with generally accepted accounting principles)
(other than trade payables entered into in the ordinary course of business), (C) all reimbursement or payment obligations with
respect to letters of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures
or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or
businesses, (E) all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred
as financing, in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though
the rights and remedies of the seller or bank under such agreement in the event of default are limited to repossession or sale
of such property) required by US GAAP to be disclosed in the Company’s financial statements, (F) all monetary obligations
under any leasing or similar arrangement which, in connection with generally accepted accounting principles, consistently applied
for the periods covered thereby, is classified as a capital lease, (G) all indebtedness referred to in clauses (A) through (F)
above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured by)
any mortgage, claim, lien, tax, right of first refusal, pledge, charge, security interest or other encumbrance upon or in any
property or assets (including accounts and contract rights) owned by any Person, even though the Person which owns such assets
or property has not assumed or become liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect
of indebtedness or obligations of others of the kinds referred to in clauses (A) through (G) above; (y) “Contingent
Obligation” means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with
respect to any indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person
incurring such liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability
will be paid or discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability
will be protected (in whole or in part) against loss with respect thereto; and (z) “Person” means an
individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and any Governmental Entity or any department or agency thereof.

 

(n)
No Undisclosed Events, Liabilities, Developments or Circumstances. Except as set forth in the SEC Filings and except for
the transactions contemplated hereby, no event, liability, development or circumstance has occurred or exists, or is reasonably
expected to exist or occur with respect to the Company, any of its Subsidiaries or any of their respective businesses, properties,
liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that (i) would be required
to be disclosed by the Company under applicable securities laws on a registration statement on Form S-1 filed with the SEC relating
to an issuance and sale by the Company of its Common Stock and which has not been publicly announced, (ii) could have a material
adverse effect on any subscriber’s investment hereunder or (iii) would reasonably be expected to have a Material Adverse
Effect.

 

(o)
No Disqualification Events. To the Company’s knowledge, none of the Company, any of its predecessors, any affiliated
issuer, any director, executive officer, other officer of the Company participating in the offering contemplated hereby, any beneficial
owner of 20% or more of the Company’s outstanding voting equity securities, calculated on the basis of voting power, nor
any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company in any capacity at the
time of sale (each, an “Issuer Covered Person”) is subject to any of the “Bad Actor” disqualifications
described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a “Disqualification Event”), except
for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine whether
any Issuer Covered Person is subject to a Disqualification Event.

 

    	- 10 -

     

    

 

(p)
General Solicitation. None of the Company, any of its affiliates (as defined in Rule 501(b) under the Securities Act) or
any person acting on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by
means of any form of general solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement,
article, notice or other communication published in any newspaper, magazine or similar medium or broadcast over television or
radio; and (ii) any seminar or meeting whose attendees have been invited by any general solicitation or general advertising.

 

(q)
Application of Takeover Protections; Rights Agreement. The Company and its board of directors have taken all necessary
action, if any, in order to render inapplicable any control share acquisition, interested stockholder, business combination, poison
pill (including, without limitation, any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover
provision under its certificate of incorporation, bylaws or other organizational documents or the laws of the jurisdiction of
its incorporation or otherwise which is or could become applicable to the undersigned subscriber as a result of the transactions
contemplated by the Transaction Documents, including, without limitation, the Company’s issuance of the Securities and any
subscriber’s ownership of the Securities. The Company and its board of directors have taken all necessary action, if any,
in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership
of shares of Common Stock or a change in control of the Company or any of its Subsidiaries. No claim will be made or enforced
by the Company or, to the knowledge of the Company, any other person that any subscriber is an “Acquiring Person”
under any shareholder rights plan or similar plan or arrangement in effect or hereafter adopted by the Company, or that any subscriber
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under this Subscription
Agreement or the Warrant or under any other agreement between the Company and any subscriber.

 

4.
SUBSCRIPTION PROCEDURES

 

The
Company shall have the right to accept or reject this subscription, in whole or in part, and this subscription shall be deemed
to be accepted by the Company only when a copy of the signature page of this Subscription Agreement is executed by the Company.
A prospective Subscriber will only own any Note and become the holder of a Warrant therein upon acceptance of the Subscription
Agreement. A minimum investment (lending commitment) of $500,000 is required. Subscriptions need not be accepted in the order
received by the Company. The undersigned understands and agrees that this subscription may be accepted or rejected by the Company,
in whole or in part in its sole and absolute discretion, and if accepted, the Securities purchased pursuant hereto will be issued
only in the name of the undersigned. The undersigned hereby acknowledges and agrees that, except as otherwise provided by applicable
state law, this Subscription Agreement may not be canceled, revoked or withdrawn, and that this Subscription Agreement and the
documents submitted herewith shall survive (i) changes in the transactions, documents and instruments that are not material, and
(ii) death or disability of the undersigned.

 

5.
INDEMNIFICATION

 

The
Company will indemnify and hold harmless each subscriber and, where applicable, its directors, officers, employees, agents, advisors,
affiliates and shareholders (each, an “Indemnitee”, from and against any and all loss, liability, claim,
damage and expense whatsoever (including, but not limited to, any and all fees, costs and expenses whatsoever reasonably incurred
in investigating, preparing or defending against any claim, lawsuit, administrative proceeding or investigation whether commenced
or threatened) (the “Indemnified Liabilities”), incurred by any Indemnitee as a result of, or arising
out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the Company in any of the
Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company contained in any of the Transaction
Documents or (iii) any cause of action, suit, proceeding or claim brought or made against such Indemnitee by a third party (including
for these purposes a derivative action brought on behalf of the Company or any Subsidiary) or which otherwise involves such Indemnitee
that arises out of or results from (A) the execution, delivery, performance or enforcement of the Transaction Documents, (B) any
transaction financed or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities,
or (C) the status of such subscriber or holder of the Securities either as an investor in the Company pursuant to the transactions
contemplated hereby or as a party to the Transaction Documents (including, without limitation, as a party in interest or otherwise
in any action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company
may be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of
the Indemnified Liabilities which is permissible under applicable law. The amount of any Indemnified Liability shall be net of
(i) any amounts recovered by the Indemnitee in respect of such Indemnified Liability pursuant to any indemnification by or indemnification
agreement with any third party (net of any costs of recovery), (ii) any insurance proceeds actually received by the Indemnity
in respect of the Indemnified Liability (net of any deductible amounts or associated incremental premiums that the Indemnitee
reasonably expects to incur as a result of the claim) and (iii) any tax benefit to the Indemnitee, to the extent such tax benefit
relates solely to such Indemnified Liability. Notwithstanding anything contained herein to the contrary, an Indemnitee shall not
be required to seek to recover any amounts, proceeds or benefits referred to in the immediately preceding sentence as a condition
precedent to seeking indemnification from the Company pursuant to this Section 5.

 

    	- 11 -

     

    

 

6.
RESTRICTIONS OF TRANSFER

 

(a)
Legends. The subscriber understands that the Securities have been issued (or will be issued in the case of the Warrant
Shares) pursuant to an exemption from registration or qualification under the Securities Act and applicable state securities laws,
and except as set forth in Section 6(b) below, the Securities shall bear any legend as required by the “blue sky”
laws of any state and a restrictive legend in substantially the following form (and a stop-transfer order may be placed against
transfer of such stock certificates):

 

NEITHER
THIS SECURITY NOR THE SECURITIES UNDERLYING THIS SECURITY HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR APPLICABLE STATE SECURITIES LAWS, UNLESS SOLD PURSUANT TO: (1) RULE 144 UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (2)
AN OPINION OF HOLDER’S COUNSEL, IN A CUSTOMARY FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE
SECURITIES LAWS.

 

(b)
Removal of Legends. Certificates evidencing Securities shall not be required to contain the legend set forth in Section
6(a) above or any other legend (i) while a registration statement covering the resale of such Securities is effective under the
Securities Act, (ii) following any sale of such Securities pursuant to Rule 144 under the Securities Act (assuming the transferor
is not an affiliate of the Company), (iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144
under the Securities Act (provided that the Investor provides the Company with reasonable assurances that such Securities are
eligible for sale, assignment or transfer under Rule 144 which shall not include an opinion of counsel), (iv) in connection with
a sale, assignment or other transfer (other than under Rule 144), provided that such subscriber provides the Company with an opinion
of counsel to such subscriber, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities
may be made without registration under the applicable requirements of the Securities Act or (v) if such legend is not required
under applicable requirements of the Securities Act (including, without limitation, controlling judicial interpretations and pronouncements
issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later than three (3) Business
Days following the delivery by the subscriber to the Company or the transfer agent (with notice to the Company) of a legended
certificate representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form
necessary to affect the reissuance and/or transfer, if applicable), as directed by such subscriber, either: (A) provided that
the Company’s transfer agent is participating in the DTC Fast Automated Securities Transfer Program and such Securities
are Warrant Shares, credit the aggregate number of shares of Common Stock to which such subscriber shall be entitled to such subscriber’s
or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s
transfer agent is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver at the Company’s
expense (via reputable overnight courier) to such subscriber, a certificate representing such Securities that is free from all
restrictive and other legends, registered in the name of such subscriber or its designee (the date by which such credit is so
required to be made to the balance account of such subscriber’s or such subscriber’s nominee with DTC or such certificate
is required to be delivered to such subscriber pursuant to the foregoing is referred to herein as the “Required Delivery
Date”). If the Company fails to (i) issue and deliver (or cause to be delivered) to the subscriber by the Required
Delivery Date a certificate representing Warrant Shares so delivered to the Company by such subscriber that is free from all restrictive
and other legends or (ii) credit the balance account of such subscriber’s or such subscriber’s nominee with DTC for
such number of Warrant Shares so delivered to the Company, and if after such date the subscriber is required to effect a Buy-In
(as defined in the Warrant), then, in addition to all other remedies available to such subscriber, the Company shall pay in cash
to such subscriber the amount set forth in Section 2(d)(iv) of the Warrant.

 

    	- 12 -

     

    

 

7.
SOCIAL SECURITY OR TAXPAYER IDENTIFICATION NUMBER

 

The
undersigned, under penalties of perjury, certifies that the taxpayer identification number or Social Security number shown hereon
is true and correct and that the undersigned is not subject to any withholding either because the undersigned has not been notified
that the undersigned is subject to backup withholding as a result of failure to report all interest or dividends or because the
Internal Revenue Service has notified the undersigned that the undersigned is no longer subject to backup withholding.

 

8.
FURTHER COVENANTS

 

(a)
Securities Laws Disclosure; Publicity. If required under the Exchange Act, the Company shall within four (4) Business Days
after this Subscription Agreement has been executed, file a Current Report on Form 8-K with the SEC, including the Transaction
Documents as exhibits thereto (the “8-K Filing”). From and after the filing of the 8-K Filing, the Company
shall have publicly disclosed all material, non-public information delivered to any of the subscribers by the Company or any of
its Subsidiaries, or any of their respective officers, directors, employees or agents. No subscriber shall issue any such press
release or otherwise make any such public statement without the prior consent of the Company, which consent shall not unreasonably
be withheld.

 

(b)
Integration. The Company shall not, and shall use its best efforts to ensure that no affiliate of the Company shall, after
the date hereof, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security other than additional
notes and warrants issued hereunder that would be integrated with the offer or sale of the Securities in a manner that would require
the registration under the Securities Act of the sale of the Securities to the subscribers.

 

    	- 13 -

     

    

 

(c)
Reservation of Securities. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Warrant in such amount as may be required to fulfill its obligations in full under the Warrant. In the event that
at any time the then authorized shares of Common Stock are insufficient for the Company to satisfy its obligations in full under
the Warrant, the Company shall promptly take such actions as may be required to increase the number of authorized shares.

 

(d)
Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated hereby,
the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any subscriber or its
agents or counsel with any information that the Company believes constitutes material non-public information. The Company understands
and confirms that each subscriber shall be relying on the foregoing covenant in effecting transactions in securities of the Company.
In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their
respective officers, directors, affiliates, employees or agents, on the one hand, and the subscriber or any of its affiliates,
on the other hand, shall terminate.

 

(e)
Accounts and Records; Inspections. The Company shall keep true records and books of account in which full, true and correct
entries will be made of all dealings or transactions in relation to the business and affairs of the Company and its subsidiaries
in accordance with GAAP applied on a consistent basis. The Company shall permit each holder of any Securities or any of such holder’s
officers, employees or representatives during regular business hours of the Company, upon reasonable notice and as often as such
holder may reasonably request, to visit and inspect the offices and properties of the Company and its subsidiaries and to make
extracts or copies of the books, accounts and records of the Company or its subsidiaries at such holder’s expense. Nothing
contained in this Section shall be construed to limit any rights which a holder of any Securities may otherwise have with respect
to the books and records of the Company and its Subsidiaries, to inspect its properties or to discuss its affairs, finances and
accounts.

 

9.
GENERAL PROVISIONS

 

	 	(a)	This
    Subscription Agreement will be governed by and construed in accordance with the substantive laws of the State of Delaware
    without regard thereof relating to conflicts of laws.
	 	 	 
	 	(b)	This
    Subscription Agreement, together with the Note, the Security Agreement and the Warrant constitutes the entire agreement between
    the parties with respect to the subject matter and supersedes any prior agreements between the parties. This Subscription
    Agreement may be amended only by a writing executed by the parties.
	 	 	 
	 	(c)	The
    Note or Warrant will be assigned or transferred only in accordance with applicable law and the terms of this Subscription
    Agreement and the Note or Warrant, as the case may be.
	 	 	 
	 	(d)	This
    Subscription Agreement will survive the undersigned’s death or dissolution and will be binding upon the undersigned’s
    successors, heirs, assignees, representatives and distributees.
	 	 	 
	 	(e)	If
    any provision of this Subscription Agreement is invalid or unenforceable under any applicable law, then such provision shall
    be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified only to the extent necessary
    to conform to such applicable law. Any provision hereof that may be held invalid or unenforceable under any applicable law
    shall not affect the validity or enforceability of any other provisions hereof, and to this extent the provisions hereof shall
    be severable.

 

    	- 14 -

     

    

 

	 	(f)	The
    parties’ representations and warranties in the Transaction Documents shall survive the execution and delivery of such
    Transaction Documents.
	 	 	 
	 	(g)	Within
    five days after receipt of a request from the Company, the undersigned hereby agrees to provide such reasonable information
    and to execute and deliver such documents as may be reasonably necessary to comply with any and all laws to which the Company
    is subject.
	 	 	 
	 	(h)	The
    Company shall reimburse the reasonable, documented legal fees incurred by the Subscribers in preparing and negotiating the
    Transaction Documents; provided that, in no event shall the Company reimburse more than $10,000 in the aggregate.

 

10.
SUBSCRIPTION

 

The undersigned hereby
subscribes for a Five Hundred Thousand Dollar ($500,000) Note to be issued by the Company, the Warrant and 17,000 Warrant Shares.
The undersigned understands that this subscription is and shall be irrevocable after passage of any right of rescission required
by applicable state law.

 

1.
The Subscriber is [  ]/ is not [X] please check as appropriate) a “benefit plan investor.”

 

A
“benefit plan investor” is a plan described in 19 C.F.R. Section 2510.3-101(f)(2) issued by the United States
Department of Labor i.e., any employee benefit plan, whether or not subject to Title I of the Employee Retirement Income
Security Act of 1974, as amended (“ERISA”), or other plan subject to the prohibited transaction provisions of Section
4975 of the Internal Revenue Code of 1986, as amended (“Code”)) or an entity whose assets are deemed “plan
assets” for purposes of Title I of ERISA and Section 4975 of the code.

 

If
the Subscriber is a benefit plan investor (a “Plan”), it is so because it is (please check as appropriate):

 

[  ]
an employee benefit plan within the meaning of and subject to Title I or ERISA (an “ERISA Plan”); or

 

[  ]
an entity whose assets are deemed to constitute “plan assets” for purposes of Title I of ERISA and Section 4975 of
the Code (also an “ERISA Plan”).

 

2.
The Subscriber is [  ]/ is not [X] (please check as appropriate) exempt from U.S. federal income tax under the Code.
If the Subscriber is tax-exempt, please attach to this Agreement a copy of the Determination Letter from the Internal Revenue
Service regarding the Subscriber’s tax-exempt status.

 

3.
The Subscriber is [  ]/ is not [X] (please check as appropriate) a “venture capital operating company”
as such term is defined in 29 CFR Section 2510.3-101.

 

    	- 15 -

     

    

 

4.
Does the undersigned grant permission to the Company to identify the undersigned by name as an investor in the Company to prospective
investors in the Company.

 

[X] Yes

 

[  ]
No

 

The
undersigned represents that the undersigned has read this Subscription Agreement.

 

The
wire instructions in connection with the subscription for the Note are as follows:

 

Bank:

 

ABA
#:

 

Account
Name:

 

Account
#:

 

(The
remainder of this page is intentionally left blank)

 

    	- 16 -

     

    

 

IN
WITNESS WHEREOF, the Company has executed this Subscription Agreement as of the 11th day of December, 2015, at _______________,
_______________.

                           (City)                          (State)

 

	 	COMPANY:
	 	 
	 	PROPHASE
    LABS, INC. 
	 	 
	 	By:	/s/
    Ted Karkus
	 	Name:	Ted
    Karkus
	 	Title:	Chief Executive Officer

 

    	- 17 -

     

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Subscription Agreement as of the _____ day of ___________, 201_, at _______________,
_______________.

                                                    (City)                           (State)

 

BUSINESS
ENTITIES

 

	 	 
	Name
    of Business Entity	 
	 	 	 
	TIN	 	 
	 	 	 
	By:
    	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:
    	 	 
	 	 	 
	 	 
	State
    of Organization	 
	 	 
	 	 
	Business
    Address	 
	 	 
	 	 
	Telephone
    Number	 
	 	 
	 	 
	Facsimile
    Number	 
	 	 
	 	 
	E-mail
    Address	 

 

    	- 18 -

     

    

 

IN
WITNESS WHEREOF, the undersigned has executed this Subscription Agreement as of the _____ day of ___________, 201_, at _______________,
_______________.

                                                      (City)                          (State)

 

TRUSTS
OR PLANS

 

	 	 
	Name
    of Trust or Plan	 
	 	 	 
	TIN
    	 	 
	 	 	 
	By:
    	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:
    	 	 
	 	 
	 	 
	State
    of Formation, if applicable	 
	 	 
	 	 
	Plan
    Address	 
	 	 
	 	 
	Telephone
    Number	 
	 	 
	 	 
	Facsimile
    Number	 
	 	 
	 	 
	E-mail
    Address	 
	 	 

 

    	- 19 -

     

    

 

IN
WITNESS WHEREROF, the undersigned has executed this Subscription Agreement as of the 11th day of December, 2015, at ____________________,
_________________.

                                                     (City)                                 
(State)

 

INDIVIDUALS

 

	/s/
    Justin J. Leonard	 	 
	Signature
    of Prospective Investor	 	Signature
    of Co-Owner or Spouse (if applicable)
	 	 	 
	SSN:	 	 	SSN:	 
	 	 	 
	 	 	 
	Typed
    or printed FULL Name of Prospective Investor	 	Typed
    or Printed FULL name of Co-Owner or Spouse (if applicable)
	 	 	 
	State
    of Residence	 	State
    of Residence
	 	 	 
	 	 	 
	Employer	 	Employer
	 	 	 
	 	 	 
	Occupation	 	Occupation
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Business/Home
    Address	 	Business/Home
    Address
	 	 	 
	 	 	 
	Facsimile
    Number	 	Facsimile
    Number
	 	 	 
	 	 	 
	E-mail
    Address	 	E-mail
    Address

 

Send
correspondence to

 

	 	Home	 	 	Office	 	 

 

    	- 20 -THIS
NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR UNDER ANY APPLICABLE
STATE SECURITIES LAWS AND HAS NOT OTHERWISE QUALIFIED FOR SALE IN RELIANCE UPON EXCEPTIONS FROM THE REQUIREMENTS OF THE SECURITIES
ACT AND STATE SECURITIES LAWS AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED
OTHER THAN PURSUANT TO THE PROVISIONS OF THE SECURITIES ACT AND STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION THEREUNDER.
THE TRANSFER HEREOF IS SUBJECT TO COMPLIANCE WITH THE CONDITIONS SPECIFIED HEREIN AND NO TRANSFER SHALL BE VALID OR EFFECTIVE,
NOR SHALL THE OBLIGOR (DEFINED BELOW) OR ITS TRANSFER AGENT BE REQUIRED TO TRANSFER SUCH NOTE OF RECORD, UNLESS AND UNTIL SUCH
CONDITIONS HAVE BEEN FULFILLED.

 

12%
SECURED PROMISSORY NOTE –
SERIES A

 

	December
    11, 2015	[                     ]

 

FOR
VALUE RECEIVED, the undersigned, ProPhase Labs, Inc., a Delaware corporation
(“ProPhase”), Pharmaloz Manufacturing Inc., a Delaware corporation (“Pharmaloz”),
and Quigley Pharma Inc., a Delaware corporation (“Quigley”, together with ProPhase, and Pharmaloz, individually
and collectively, the “Obligor”), jointly and severally hereby promises to pay to the order of [       ]
(“Holder”) at such place as Holder may from time to time direct, in lawful money of the United States,
the principal sum of [                                   ](
              ) (the “Principal Amount”),
plus interest accrued on the unpaid Principal Amount (the “Accrued Interest”) at a rate equal to twelve
percent (12%) per annum (the “Interest Rate”), calculated from the date hereof on a basis of a 365 day
year but computed for the actual number of days elapsed, in the amounts, at the times, in the manner and subject to the terms
and conditions as provided below. As additional consideration for this Note, Obligor is concurrently issuing Holder a warrant
for the purchase of Common Stock of ProPhase (the “Warrant”) as further described in the Subscription
Agreement dated as of December 11, 2015, by and between the Obligor and the Holder (the “Subscription Agreement”).
From and after the occurrence of an Event of Default under this Note (including the failure of the Obligor to pay all amounts
outstanding under this Note on the Maturity Date), and so long as such Event of Default shall continue in effect, the outstanding
Principal Amount of this Note shall bear interest at a rate equal to fifteen (15%) per annum (“Default Interest”).

 

This
Note is one of a series of 12% Promissory Notes –Series A of the Obligor in the aggregate amount of up to $3,000,000 (collectively,
the “Series A Notes”). Obligor is also issuing warrants in form substantially similar to the Warrant
to the other holders of Series A Notes (such warrants, together with the Warrant, the “Warrants”). The
Series A Notes shall be pari passu with respect to each other and all payments to the Holders under the Series A Notes shall be
made pro rata among the Holders based on the aggregate unpaid Principal Amount and Accrued Interest of the Series A Note(s) held
by the Holders. If Holder obtains any payment (whether voluntary, involuntary, by application of offset or otherwise) of principal,
interest, premium or other amount with respect to this Note in excess of Holder’s pro rata share of such payments obtained
by all of the Holders, then, by acceptance of this Note, Holder agrees to distribute to the other Holders an amount sufficient
to cause all of the Holders to receive their respective pro rata share of any payment of principal, interest, premium or other
amount with respect to the Series A Notes.

 

    	 

     

    

 

The
obligations of Obligor under this Note, as well as under the other Series A Notes, are secured by a first priority perfected security
interest in the Collateral, as such term is defined in that certain Security Agreement, dated as of even date herewith, executed
by the Obligor in favor of [              ], as collateral
agent for the secured parties referred to therein (the “Collateral Agent”). Holder hereby appoints [                            ],
as Collateral Agent to hold the security granted under the Security Agreement for the benefit of Holder and such other holders,
and authorizes the Collateral Agent to take all actions and exercise all rights with respect to the Collateral under the Security
Agreement on Holder’s behalf, without the requirement of receiving consent from Holder upon the Collateral Agent’s
receipt of consent and authorization from any combination of the Holders who or which, collectively, represent a majority (more
than 50%) of the principal outstanding under all of the Series A Notes (collectively, the “Requisite Holder(s)”),
provided that Collateral Agent delivers written notice to Holder (email shall suffice) at least five (5) days prior to the taking
of any such action or the exercise of any such right, except that Collateral Agent shall not, without Holder’s prior written
consent (i) exercise any such rights as to Holder which would increase or decrease the Principal Amount of or Accrued Interest
under this Note or the rate of interest payable hereunder; or (ii) exercise any such rights as to Holder unless the exercise thereof
applies to all of the Holders in the same relative fashion.

 

1.
Payments of Principal and Interest.

 

(a)Obligor
will pay Holder interest on the unpaid principal balance of this Note at the Interest Rate in semi-annual installments commencing
on June 15, 2016, and continuing on December 14, 2016 and June 15, 2017.

 

(b)Obligor
will pay Holder the Principal Amount in full on June 15, 2017 (the “Maturity Date”).

 

(c)The
Principal Amount, together with all unpaid Accrued Interest thereon, may be prepaid by Obligor in whole or in part, at any time
and from time to time with no penalty. Any such prepayment shall be accompanied by all unpaid Accrued Interest on the principal
amount so prepaid.

 

(d)Obligor
will pay Holder Default Interest (if applicable) upon demand by Holder.

 

(e)Upon
the payment in full of all amounts owing under this Note, (i) Holder shall deliver this Note to Obligor for cancellation (or Holder
shall deliver an indemnity agreement reasonably satisfactory to Obligor), (ii) all security interests granted under the Security
Agreement shall be automatically terminated and liens and security interests released as set forth in the Security Agreement.

 

2.Events
of Default and Remedies. Each of the following events shall constitute an event of default (an “Event of Default”)
under this Note:

 

(a)Obligor
shall have defaulted in the payment of all or any part of the Accrued Interest or the Principal Amount due under or pursuant to
this Note or any other Series A Note as and when the same shall become due and payable, and such default shall have continued
for five (5) days after the date such payment was due;

 

(b)Any
Obligor, pursuant to or within the meaning of Title 11, U.S. Code or any similar federal or state law for the relief of debtors
(collectively, “Bankruptcy Law”) shall have (i) commenced a voluntary case or proceeding, (ii) consented
to the entry of an order for relief against it in an involuntary case or proceeding, (iii) consented to the appointment of a custodian
of it or for all or substantially all of its property, (iv) made a general assignment for the benefit of its creditors or (v)
admitted in writing its inability generally to pay its debts as the same become due;

 

(c)a
court of competent jurisdiction shall have entered an order or decree under any Bankruptcy Law that: (i) is for relief against
any Obligor in an involuntary case, (ii) appoints a custodian of any Obligor or for all or substantially all of the property of
any Obligor or (iii) orders the liquidation of any Obligor, and in any such case such order or decree shall not have been withdrawn,
dismissed or stayed for sixty (60) days;

 

    	2

     

    

 

(d)Any
Obligor shall have defaulted with respect to the payment of any indebtedness other than the Series A Notes in an aggregate amount
of in excess of [                            ]
(              ), or any other event of default shall
have occurred under any such indebtedness, which default has resulted in the acceleration of such indebtedness and such indebtedness
shall not have been paid, or such acceleration rescinded, within forty-five (45) days from the date of such default;

 

(e)the
institution by any Obligor of any liquidation, dissolution or winding up of the affairs of Obligor without sufficient reserves
to redeem this Note in accordance with its terms prior to such event;

 

(f)If
at any time while this Note is outstanding, (i) any Obligor, directly or indirectly, in one or more related transactions effects
any merger or consolidation of the Obligor with or into another person, (ii) any Obligor, directly or indirectly, effects any
sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or
a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Obligor or another person) is completed pursuant to which holders of Common Stock of ProPhase (“Common Stock”)
are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock, (iv) ProPhase, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, (v) ProPhase, directly or
indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination
(including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another person whereby
such other person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held
by the other Person or other Persons making or party to, or associated or affiliated with the other persons making or party to,
such stock or share purchase agreement or other business combination. Notwithstanding the foregoing, nothing herein shall restrict
or prohibit ProPhase and the Obligors from implementing an internal corporate restructuring, including by merger, consolidation,
transfer of assets, or otherwise.

 

If
an Event of Default shall have occurred and be continuing, Requisite Holder(s), by notice in writing to Obligor and to the Collateral
Agent (the “Acceleration Notice”), may declare the unpaid Principal Amount hereunder and all unpaid
Accrued Interest hereon to be due and payable immediately, and upon any such declaration the same shall become immediately due
and payable; provided, however, that, if an Event of Default specified in Section 2(b) or 2(c) above
shall have occurred, the unpaid Principal Amount hereunder and all Accrued Interest hereon shall become and be immediately due
and payable without any declaration or other act on the part of the Requisite Holders.

 

If
any Event of Default shall have occurred, Obligor shall reimburse Holder, on demand, for any and all reasonable costs and expenses,
including reasonable documented attorneys’ fees and court costs, incurred by Holder in collecting or otherwise enforcing
this Note.

 

3.Powers
and Remedies Cumulative; Delay or Omission Not Waiver of Default. No right or remedy herein conferred upon or reserved to
Holder is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by
law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity
or otherwise. Except as otherwise provided by law, the assertion or employment of any right or remedy hereunder, or otherwise,
shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.

 

No
delay or omission of Holder to exercise any right or power accruing upon any Event of Default shall impair any such right or power
or shall be construed to be a waiver of any such Event of Default or an acquiescence therein; and except as otherwise provided
by law, every power and remedy given by this Note or by law may be exercised from time to time, and as often as shall be deemed
expedient, by Holder.

 

    	3

     

    

 

4.Modification
of Note. This Note may not be amended or otherwise modified except as provided in writing signed by Obligor and Holder.

 

5.Notices.
Any notice, request, demand or other communication pursuant to this Note by Obligor or by Holder shall be in writing and shall
be delivered by hand, sent via certified or registered mail (return receipt requested), or sent by any commercial express delivery
or courier service (with receipt), effective upon delivery in person, or, if mailed, on the first day after the date of mailing,
addressed as follows:

 

	 	If
    to Obligor:	ProPhase
    Labs, Inc.
	 	 	621
    N. Shady Retreat Road
	 	 	Doylestown,
    PA 18901
	 	 	Attn:
    Robert V. Cuddihy, Jr.
	 	 	215-345-0919
    Ext. 139

 

If
to Holder: At Holder’s address appearing at the end of Holder’s Subscription Agreement for this Note, or as otherwise
previously indicated by Holder in writing addressed to the Chief Operating Officer of Obligor.

 

6.Waiver
of Notices; Construction. To the fullest extent permitted by law, Obligor hereby waives presentment, demand, notice, protest
and all other demands and notices in connection with the delivery, acceptance, performance and enforcement of this Note and assents
to extensions of the time of payment or forbearance or other indulgence without notice. The Section headings herein are for convenience
only and shall not affect the construction hereof.

 

7.Restrictions
on Negotiability and Transfer.

 

(a)This
Note and the other Series A Notes have not been registered under the Securities Act or qualified under any applicable state securities
or “blue sky” law. This Note may not be offered, sold or otherwise transferred unless registered and qualified pursuant
to the provisions of the Act and such “blue sky” laws, or unless an exemption from registration and qualification
is available.

 

(b)By
acceptance hereof, Holder agrees, prior to any transfer or attempted transfer of this Note (other than a transfer to Obligor),
to give written notice to Obligor of the Holder’s intention to effect such transfer. Each such notice shall describe the
manner and circumstances of the proposed transfer in reasonable detail.

 

(c)By
receipt hereof, Holder hereby acknowledges and agrees that: (i) Holder is holding this Note for Holder’s own account and
without any present view towards the transfer, resale or other distribution thereof; (ii) Holder has been advised and is aware
that there is no public market for this Note or the Warrant and it is not likely that any public market for this Note will develop;
and (iii) this Note is subject to the restrictions on transfer set forth herein.

 

(d)Obligor
may not assign its rights or obligations under this Note without the prior written consent of the Holder.

 

8.Loss,
Theft, Destruction or Mutilation. Upon receipt by Obligor of reasonable evidence satisfactory to counsel to Obligor of ownership
of and the loss, theft, destruction or mutilation of this Note and (in the case of loss, theft or destruction) of reasonable indemnity
and (in the case of mutilation) upon surrender and cancellation hereof, Obligor will execute and deliver, in lieu hereof, a new
Note of like tenor.

 

    	4

     

    

 

9.Governing
Law and Jurisdiction. This Note shall take effect as a sealed instrument and shall be construed in accordance with and governed
by the laws of the State of Delaware, without reference to its conflicts of law provisions. In any legal proceeding involving,
directly or indirectly, any matter arising out of or related to this Note or the relationship evidenced hereby, Obligor and Holder
hereby irrevocably submit to the exclusive jurisdiction of the court of common pleas of Bucks County, Pennsylvania and the United
States District Court for the Eastern District of Pennsylvania. Obligor and Holder expressly submit and consent in advance to
such jurisdiction in any action or suit commenced in any such court, and Obligor and Holder hereby waive any objection which they
may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens.

 

10.Waiver
of Jury Trial. EACH OF OBLIGOR AND HOLDER WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND
ANY RIGHTS UNDER THIS NOTE OR RELATING THERETO OR ARISING FROM THE RELATIONSHIP WHICH IS THE SUBJECT OF THIS NOTE AND AGREES THAT
ANY SUCH ACTION OR PROCEEDING SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY.

 

11.No
Rights as Stockholder. This Note does not by itself entitle Holder to any voting or informational rights or other rights as
a stockholder of Obligor. In the absence of the exercise of the Warrant, no provision of this Note and no enumeration herein of
the rights or privileges of Holder shall cause Holder to be a stockholder of Obligor for any purpose.

 

12.Headings.
The descriptive headings of the several sections of this Note are inserted for convenience only and do not constitute a part of
this Note.

 

13.Miscellaneous.
The terms and provisions of this Note are severable, and if any term or provision shall be determined to be superseded, illegal,
invalid or otherwise unenforceable in whole or in part pursuant to applicable law by a governmental authority having jurisdiction,
that determination shall not in any manner impair or otherwise affect the validity, legality or enforceability of that term or
provision in any other jurisdiction or any of the remaining terms and provisions of this Note in any jurisdiction. This Note,
together with the Security Agreement, the Subscription Agreement and the Warrant constitutes the entire agreement with respect
to the subject matter hereof and supersedes all other prior or contemporaneous agreements and understandings, both written and
oral, with respect to such subject matter. This Note shall be binding upon and enforceable against Obligor and Obligor’s
permitted successors and assigns and shall inure to the benefit of and be enforceable by Holder and Holder’s heirs, beneficiaries,
executors, legal representatives, successors and permitted assigns. This Note is not intended to confer any rights or remedies
hereunder upon any Person other than Holder and Holder’s heirs, beneficiaries, executors, legal representatives, successors
and permitted assigns. If any payment on this Note becomes due and payable on a Saturday, Sunday or other day on which commercial
banks in Delaware are authorized or required by Delaware State law to close, such payment date shall be extended to the next succeeding
business day.

 

[Signature
Page Follows]

 

    	5

     

    

 

IN
WITNESS WHEREOF, Obligor has caused this instrument to be duly executed and delivered by its authorized officer as of the
date first set forth above.

 

	 	PROPHASE
    LABS, Inc.
	 	 	 
	 	By:	                      
	 	 	Ted
    Karkus, CEO
	 	 	 
	 	Pharmaloz
    Manufacturing Inc.,
	 	 	 
	 	By:	                    
	 	Name:	 
	 	Title:	 
	 	 	 
	 	Quigley
    Pharma Inc.,
	 	 	 
	 	By:	                            
	 	Name:	 
	 	Title:	 

 

Accepted
and Agreed to:

 

	 	 
	Name:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00252-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00252-of-00352.parquet"}]]